Coherus BioSciences, Inc.
CHRS
$0.7947
$0.01291.65%
CHRS market cap represents
0.00%
of the sector.
Valuation
CHRS
Low
CHRS
Sector Average
High
Market Cap
90.61M
< 90.61M
> 15.90B
Enterprise Value
263.27M
< 260.00M
> 18.12B
Price/Earnings (TTM)
5.06
< 0.00
> 10.00
Earnings Per Share Growth (TTM)
-105.99%
< -110.00%
> -10.00%
Price/Earnings To Growth (TTM)
--
0.00
11.91
Price/Sales (TTM)
0.34
< 0.000
> 440.00
Price/Book (Q)
-0.68
< -10.00
> 20.00
Enterprise Value/Revenue (TTM)
0.99
< 0.00
> 200.00
Enterprise Value/EBITDA (TTM)
-2.96
< -10.00
> 10.00
Enterprise Value/EBIT (TTM)
-2.79
< -10.00
> 10.00
Dividends and Shares
CHRS
Low
CHRS
Sector Average
High
Shares Outstanding
115.42M
< 60.00M
> 250.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
8.58%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
CHRS
Low
CHRS
Sector Average
High
Beta
0.92
< 0.00
4.98
1-Month Total Return
-24.10%
< -30.00%
> 0.00%
3-Month Total Return
-51.74%
< -60.00%
> -10.00%
6-Month Total Return
-26.93%
< -30.00%
> 0.00%
Year to Date Total Return
-44.16%
< -50.00%
> 0.00%
1-Year Total Return
-67.83%
< -70.00%
> 0.00%
2-Year Total Return
-89.82%
< -90.00%
> 20.00%
3-Year Total Return
-93.79%
-100.00%
> 0.00%
5-Year Total Return
-95.10%
-100.00%
> 150.00%
Profitability
CHRS
Low
CHRS
Sector Average
High
Operating Margin (TTM)
-35.34%
< -14,860.00%
> -30.00%
Profit Margin (TTM)
10.67%
< -11,260.00%
> 20.00%
Management Effectiveness
CHRS
Low
CHRS
Sector Average
High
Return on Assets (TTM)
-10.94%
< -50.00%
> -10.00%
Return on Equity (TTM)
--
0.26%
1,905.92%
Income Statement
CHRS
Low
CHRS
Sector Average
High
Revenue (TTM)
266.96M
< 260.00M
> 12.68B
Total Revenue (TTM)
266.96M
< 260.00M
> 12.92B
Total Revenue Growth (Q YOY)
-40.84%
< -50.00%
> 1,610.00%
Revenue Per Share (TTM)
2.31
< 0.00
> 190.00
Gross Profit (TTM)
149.41M
< 140.00M
> 3.81B
EBITDA (TTM)
-89.09M
< -90.00M
> 1.15B
EBIT (TTM)
-94.37M
< -100.00M
> 780.00M
Net Income (TTM)
28.51M
< 20.00M
> 300.00M
Net Income Avl. to Common (TTM)
28.51M
< 20.00M
> 300.00M
Earnings Growth (Q YOY)
36.35%
< -150.00%
> 40.00%
EPS Diluted (TTM)
0.15
< -4,610.00
> 10.00
EPS Diluted Growth (Q YOY)
34.87%
< 20.00%
> 90.00%
Balance Sheet
CHRS
Low
CHRS
Sector Average
High
Cash and Short-Term Inv. (Q)
125.99M
< 120.00M
> 1.44B
Cash Per Share (Q)
1.09
0.00
> 210.00
Total Current Assets (Q)
341.58M
< 340.00M
> 3.65B
Total Assets (Q)
448.53M
< 440.00M
> 10.33B
Total Current Liabilities (Q)
282.98M
< 280.00M
> 2.72B
Total Debt (Q)
298.65M
< 290.00M
> 3.32B
Total Liabilities (Q)
580.52M
< 580.00M
> 6.49B
Total Common Equity (Q)
-131.99M
< -140.00M
> 3.74B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
-131.99M
< -140.00M
> 3.84B
Current Ratio (Q)
1.207
0.086
> 20.000
Book Value Per Share (Q)
-1.14
< -10.00
> 1,210.00
Cash Flow
CHRS
Low
CHRS
Sector Average
High
Cash from Operations (TTM)
-20.44M
< -30.00M
> 760.00M
Cash from Investing (TTM)
230.32M
< -620.00M
> 240.00M
Cash from Financing (TTM)
-186.97M
< -190.00M
> -40.00M
Net Change in Cash (TTM)
22.91M
< -30.00M
> 30.00M
Levered Free Cash Flow (TTM)
41.59M
< 40.00M
> 570.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
